Cameco Corporation (USA)  

(Public, NYSE:CCJ)   Watch this stock  
Find more results for CCJ
14.88
-0.13 (-0.87%)
May 28 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 14.68 - 14.91
52 week 13.62 - 21.67
Open 14.90
Vol / Avg. 1.45M/2.29M
Mkt cap 6.01B
P/E 164.11
Div/yield 0.08/2.23
EPS 0.09
Shares 395.79M
Beta 1.70
Inst. own 70%
Jul 29, 2015
Q2 2015 Cameco Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 22, 2015
Cameco Corp Annual Shareholders Meeting - Webcast
May 13, 2015
Cameco Corp at Bank of America Global Metals and Mining Conference
Apr 29, 2015
Q1 2015 Cameco Corp Earnings Call
Apr 29, 2015
Q1 2015 Cameco Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -1.74% 2.34%
Operating margin 11.96% 1.60%
EBITD margin - 31.23%
Return on average assets -0.46% 0.68%
Return on average equity -0.65% 1.07%
Employees 3,963 -
CDP Score - 80 C

Address

2121 - 11th Street West
SASKATOON, SK S7M 1J3
Canada
+1-306-9566220 (Phone)
+1-306-9566312 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha

Description

Cameco Corporation (Cameco) is primarily engaged in the exploration for and the development, mining, refining, conversion, fabrication and trading of uranium for sale as fuel for generating electricity in nuclear power reactors in Canada and other countries. Cameco has four reportable segments: uranium, fuel services, electricity and NUKEM. The uranium segment involves the exploration for, mining, milling, purchase and sale of uranium concentrate. The fuel services segment involves the refining, conversion and fabrication of uranium concentrate and the purchase and sale of conversion services. The electricity segment involves the generation and sale of electricity. The NUKEM segment acts as a market intermediary between uranium producers and nuclear-electric utilities.

Officers and directors

Timothy S. Gitzel President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Grant E. Isaac Chief Financial Officer, Senior Vice President
Bio & Compensation  - Reuters
Robert A. Steane Chief Operating Officer, Senior Vice President
Bio & Compensation  - Reuters
Kenneth A. Seitz Senior Vice President, Chief Compliance Officer
Bio & Compensation  - Reuters
Sean Quinn Senior Vice President, Chief Legal Officer, Corporate Secretary
Bio & Compensation  - Reuters
Alice Louise Wong Senior Vice President, Chief Corporate Officer
Bio & Compensation  - Reuters
Donald H. F. Deranger Director
Age: 59
Bio & Compensation  - Reuters
Ian Bruce Independent Director
Age: 61
Bio & Compensation  - Reuters
Daniel Camus Independent Director
Age: 63
Bio & Compensation  - Reuters
John Henry Clappison Independent Director
Age: 68
Bio & Compensation  - Reuters